-
Iterum Therapeutics Reports First Quarter 2020 Financial Results
-
Iterum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
-
Iterum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
-
Iterum Therapeutics (ITRM) PT Lowered to $15 at RBC Capital
-
Iterum Therapeutics (ITRM) PT Lowered to $17 at RBC Capital
-
Iterum Therapeutics Reports First Quarter 2019 Financial Results
-
Iterum Therapeutics Reports First Quarter 2019 Financial Results
-
Iterum Therapeutics (ITRM) PT Lowered to $20 at RBC Capital
-
Iterum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
-
Iterum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
-
Iterum Therapeutics (ITRM) PT Lowered to $22 at RBC Capital
-
RBC Capital Starts Iterum Therapeutics (ITRM) at Outperform
-
Iterum Therapeutics (ITRM) IPO Opens Modeslty Lower
-
Iterum Therapeutics plc (ITRM) Prices 6.15M Share IPO at $13/Sh
-
Iterum Therapeutics Announces Pricing of Initial Public Offering